103 filings
Page 3 of 6
8-K
v5rkwea
26 Jul 07
AtheroGenics Reports Second Quarter 2007 Financial Results
12:00am
8-K
o9pir5i va6
19 Jul 07
Other Events
12:00am
8-K
0mjdvq
12 Jul 07
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
br6qvyguwkg
25 Jun 07
Unregistered Sales of Equity Securities
12:00am
8-K
6zgtsy17
22 Jun 07
Departure of Directors or Principal Officers
12:00am
8-K
m31y3k9hnuenuhndjv2j
1 Jun 07
AtheroGenics Announces Business Plan to Focus on Advancing AGI-1067 in Diabetes
12:00am
8-K
h78rpeksu 2k7g0
25 May 07
Other Events
12:00am
8-K
jllxsgtb0 0ah
26 Apr 07
AtheroGenics Reports First Quarter 2007 Financial Results
12:00am
8-K
7x6niyhk3n1boxwso2
24 Apr 07
AtheroGenics and AstraZeneca End Collaboration Agreement for AGI-1067
12:00am
8-K
6tm4t
19 Apr 07
Departure of Directors or Principal Officers
12:00am
8-K
1jicmruap40o477og
27 Mar 07
AtheroGenics Announces ARISE Phase III Clinical Study Results at the American College of Cardiology’s 56th Annual Scientific Session
12:00am
8-K
ego7 uuihodq43svk
19 Mar 07
AtheroGenics Reports ARISE Trial Results for AGI-1067
12:00am
8-K
560xm
22 Feb 07
AtheroGenics Reports Fourth Quarter and Year-End 2006 Financial Results
12:00am
8-K
h7iwim7ijgsc
9 Jan 07
AtheroGenics Refines Timing of ARISE Clinical Trial Top-line Results
12:00am
8-K
xntuv3dv5i9yowg5msv5
4 Jan 07
Departure of Directors or Principal Officers
12:00am
8-K
hoh07itmm82s
8 Dec 06
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
ceyq luz493kvk
24 Oct 06
AtheroGenics Reports Third Quarter 2006 Financial Results
12:00am
8-K
fcpsktrt jn5
29 Sep 06
Entry into a Material Definitive Agreement
12:00am
8-K
1tkmi1x99 02b0yo7
20 Jul 06
AtheroGenics Reports Second Quarter 2006 Financial Results
12:00am
8-K
l8a2utk oiq
18 Jul 06
AtheroGenics, Inc. Announces Two New Board Members
12:00am